🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Start Date
2021-05-21
Trial ID
NCT04704934
Treatments Being Tested
This is an open-label, multicenter, Phase II study to evaluate the efficacy...
Status
Active Not Recruiting
Location
Research Site
Start Date
2024-02-22
Trial ID
NCT06271837
Treatments Being Tested
A phase II, open-label, multicenter, randomized controlled trial exploring ...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-09
Trial ID
NCT07150208
Treatments Being Tested
This phase II trial compares the effect of usual treatment of docetaxel che...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-03
Trial ID
NCT05408845
The study is an open, prospective study to collect data on the efficacy and...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-30
Trial ID
NCT07035353
Treatments Being Tested
DESTINY-Gastric03 will investigate the safety, tolerability, pharmacokineti...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-06-03
Trial ID
NCT04379596
This clinical trial is designed to assess the efficacy and safety of the tr...
Status
Recruiting
Location
Yale Cancer Center
Start Date
2025-02-27
Trial ID
NCT06731478
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of T-DXd i...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-07-13
Trial ID
NCT05246514
Treatments Being Tested
Multiple trials confirm systemic T-DXd efficacy in HER2+ breast cancer with...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-04-18
Trial ID
NCT07134153
Treatments Being Tested
This is a Phase II, open-label, single-arm, multicentre, study in China ass...
Status
Completed
Location
Research Site
Start Date
2021-08-20
Trial ID
NCT04989816
Treatments Being Tested